Anthera Pharmaceuticals beats by $0.03

May 11, 2015 6:13 PM ETAnthera Pharmaceuticals, Inc. (ANTH) StockBy: Gaurav Batavia, SA News Editor
  • Anthera Pharmaceuticals (OTC:ANTH): Q1 EPS of -$0.28 beats by $0.03.
  • Revenue of $0.25M
  • Press Release

Recommended For You

More Trending News

About ANTH Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ANTH--
Anthera Pharmaceuticals, Inc.